BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30293248)

  • 21. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
    Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
    Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intersociety policy statement on the use of whole-exome sequencing in the critically ill newborn infant.
    Borghesi A; Mencarelli MA; Memo L; Ferrero GB; Bartuli A; Genuardi M; Stronati M; Villani A; Renieri A; Corsello G;
    Ital J Pediatr; 2017 Nov; 43(1):100. PubMed ID: 29100554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A kidney-disease gene panel allows a comprehensive genetic diagnosis of cystic and glomerular inherited kidney diseases.
    Bullich G; Domingo-Gallego A; Vargas I; Ruiz P; Lorente-Grandoso L; Furlano M; Fraga G; Madrid Á; Ariceta G; Borregán M; Piñero-Fernández JA; Rodríguez-Peña L; Ballesta-Martínez MJ; Llano-Rivas I; Meñica MA; Ballarín J; Torrents D; Torra R; Ars E
    Kidney Int; 2018 Aug; 94(2):363-371. PubMed ID: 29801666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study.
    Karacan İ; Balamir A; Uğurlu S; Aydın AK; Everest E; Zor S; Önen MÖ; Daşdemir S; Özkaya O; Sözeri B; Tufan A; Yıldırım DG; Yüksel S; Ayaz NA; Ömeroğlu RE; Öztürk K; Çakan M; Söylemezoğlu O; Şahin S; Barut K; Adroviç A; Seyahi E; Özdoğan H; Kasapçopur Ö; Turanlı ET
    Rheumatol Int; 2019 May; 39(5):911-919. PubMed ID: 30783801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing.
    Arunachalam AK; Maddali M; Aboobacker FN; Korula A; George B; Mathews V; Edison ES
    J Clin Immunol; 2021 Feb; 41(2):393-413. PubMed ID: 33225392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders.
    Lindy AS; Stosser MB; Butler E; Downtain-Pickersgill C; Shanmugham A; Retterer K; Brandt T; Richard G; McKnight DA
    Epilepsia; 2018 May; 59(5):1062-1071. PubMed ID: 29655203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-generation sequencing in familial breast cancer patients from Lebanon.
    Jalkh N; Chouery E; Haidar Z; Khater C; Atallah D; Ali H; Marafie MJ; Al-Mulla MR; Al-Mulla F; Megarbane A
    BMC Med Genomics; 2017 Feb; 10(1):8. PubMed ID: 28202063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular diagnosis in patients with monogenic diabetes mellitus, and detection of a novel candidate gene.
    Goksen D; Evin F; Isik E; Ozen S; Atik T; Ozkinay F; Akcan N; Ozkan B; Buyukinan M; Nuri Ozbek M; Darcan S; Onay H
    Diabetes Res Clin Pract; 2023 Nov; 205():110953. PubMed ID: 37838154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining Panel-Based Next-Generation Sequencing and Exome Sequencing for Genetic Liver Diseases.
    Chen CB; Hsu JS; Chen PL; Wu JF; Li HY; Liou BY; Chang MH; Ni YH; Hwu WL; Chien YH; Chou YY; Yang YJ; Lee NC; Chen HL
    J Pediatr; 2023 Jul; 258():113408. PubMed ID: 37019333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
    Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
    Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation spectrum of hereditary myopathies in Turkish patients and novel variants.
    Saat H; Sahin I
    Ann Hum Genet; 2021 Sep; 85(5):178-185. PubMed ID: 33963534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Utility of Whole Exome Sequencing and Targeted Panels for the Identification of Inborn Errors of Immunity in a Resource-Constrained Setting.
    Engelbrecht C; Urban M; Schoeman M; Paarwater B; van Coller A; Abraham DR; Cornelissen H; Glashoff R; Esser M; Möller M; Kinnear C; Glanzmann B
    Front Immunol; 2021; 12():665621. PubMed ID: 34093558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.
    Bastida JM; Del Rey M; Lozano ML; Sarasquete ME; Benito R; Fontecha ME; Fisac R; García-Frade LJ; Aguilar C; Martínez MP; Pardal E; Aguilera C; Pérez B; Ramos R; Cardesa MR; Martin-Antorán JM; Silvestre LA; Cebeira MJ; Bermejo N; Riesco S; Mendoza MC; García-Sanz R; González-Díaz M; Hernández-Rivas JM; González-Porras JR
    Haemophilia; 2016 Jul; 22(4):590-7. PubMed ID: 26879396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.
    Harris E; Topf A; Barresi R; Hudson J; Powell H; Tellez J; Hicks D; Porter A; Bertoli M; Evangelista T; Marini-Betollo C; Magnússon Ó; Lek M; MacArthur D; Bushby K; Lochmüller H; Straub V
    Orphanet J Rare Dis; 2017 Sep; 12(1):151. PubMed ID: 28877744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact on Clinical Decision Making of Next-Generation Sequencing in Pediatric Epilepsy in a Tertiary Epilepsy Referral Center.
    Hoelz H; Herdl C; Gerstl L; Tacke M; Vill K; von Stuelpnagel C; Rost I; Hoertnagel K; Abicht A; Hollizeck S; Larsen LHG; Borggraefe I
    Clin EEG Neurosci; 2020 Jan; 51(1):61-69. PubMed ID: 31554424
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of mutations in inherited retinal diseases: A comparison between the United States and India.
    Yohe S; Sivasankar M; Ghosh A; Ghosh A; Holle J; Murugan S; Gupta R; Schimmenti LA; Vedam R; Thyagarajan B
    Mol Genet Genomic Med; 2020 Feb; 8(2):e1081. PubMed ID: 31816670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large gene panel sequencing in clinical diagnostics-results from 501 consecutive cases.
    Pajusalu S; Kahre T; Roomere H; Murumets Ü; Roht L; Simenson K; Reimand T; Õunap K
    Clin Genet; 2018 Jan; 93(1):78-83. PubMed ID: 28378410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation.
    Bacquet J; Stojkovic T; Boyer A; Martini N; Audic F; Chabrol B; Salort-Campana E; Delmont E; Desvignes JP; Verschueren A; Attarian S; Chaussenot A; Delague V; Levy N; Bonello-Palot N
    BMJ Open; 2018 Oct; 8(10):e021632. PubMed ID: 30373780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study.
    Schon KR; Horvath R; Wei W; Calabrese C; Tucci A; Ibañez K; Ratnaike T; Pitceathly RDS; Bugiardini E; Quinlivan R; Hanna MG; Clement E; Ashton E; Sayer JA; Brennan P; Josifova D; Izatt L; Fratter C; Nesbitt V; Barrett T; McMullen DJ; Smith A; Deshpande C; Smithson SF; Festenstein R; Canham N; Caulfield M; Houlden H; Rahman S; Chinnery PF;
    BMJ; 2021 Nov; 375():e066288. PubMed ID: 34732400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases.
    Saudi Mendeliome Group
    Genome Biol; 2015 Jun; 16(1):134. PubMed ID: 26112015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.